Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 127

Sort by

Sort Order Select

Journal Articles

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Binod Dhakal, MBBS, Muhammad Umair Mushtaq, MD, Ashley Cunningham, MD, Athanasios Papadas, MD, Adam Pagenkopf, BS, Joshua Wiesner, Catherine Leith, MBBChir, Peiman Hematti, MD, Parameswaran Hari, MBBS, MD, Natalie Scott Callander, MD, Fotis Asimakopoulos, PhDMBBChir,

Blood (2019) 134 (Supplement_1): 3088.

https://doi.org/10.1182/blood-2019-127565

Published: 2019

Journal Articles

Disruption of ADAMTS13-Autoantibody Complexes with an ADAMTS13 Spacer Domain As a Potential Therapeutic Strategy for Immune Thrombotic Thrombocytopenic Purpura

Konstantine Halkidis, MD PhD, X. Long Zheng, MD, PhD

Blood (2019) 134 (Supplement_1): 88.

https://doi.org/10.1182/blood-2019-125965

Published: 2019

Journal Articles

Plasmic and Plasic Αre Εxcellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes

Blood (2019) 134 (Supplement_1): 4913.

https://doi.org/10.1182/blood-2019-125343

Published: 2019

Journal Articles

ADAMTS13, an Anti-thrombotic Protein: Evidence Outside of Thrombotic Thrombocytopenic Purpura

Simon De Meyer, PhD

Blood (2019) 134 (Supplement_1): SCI-41.

https://doi.org/10.1182/blood-2019-121114

Published: 2019

Journal Articles

Thrombotic Thrombocytopenia Purpura Case Series in Skmc 2016-2017

Mohamed Abu Haleeqa, MBBS, Hanan Al Raeesi, MBBS, Fatima Alkaabi, MBBS

Blood (2019) 134 (Supplement_1): 4799.

https://doi.org/10.1182/blood-2019-126479

Published: 2019

Journal Articles

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Blood (2019) 133 (15): 1644–1651.

https://doi.org/10.1182/blood-2018-11-884700

Published: 2019

Journal Articles

Single Centre UK Comparison of Biosimilar Rituximab (Truxima) with the Originator (MabThera) in Patients with Immune Mediated Thrombotic Thrombocytopenic Purpura

Matthew J. Stubbs, MBBS, MRCP, FRCPath, Ryan Low, MBChB, Siobhan McGuckin, Rosalind Newton, John-Paul Westwood, MD, Mari Thomas, PhD, Simon Cheesman, BPharm, Marie Scully, MD MRCP, FRCPath

Blood (2018) 132 (Supplement 1): 3750.

https://doi.org/10.1182/blood-2018-99-114765

Published: 2018

Journal Articles

A New Flow-Based Assay to Assess Treatment Response in Congenital Thrombotic Thrombocytopenic Purpura

Ferras Alwan, Chiara Vendramin, Alice Taylor, Mari Thomas, PhD, Ri Liesner, Marie Scully, MD MRCP, FRCPath

Blood (2018) 132 (Supplement 1): 2441.

https://doi.org/10.1182/blood-2018-99-115965

Published: 2018

Journal Articles

Vascular Proteomics Reveals Critical Roles of ADAMTS18 in Stroke Associated with Imbalanced Level of Von Willebrand Factor Versus ADAMTS13

Rui Zhu, Yi-Hsuan Pan, Tiantian Lu, Suying Dang, Chen-Chung Liao, Wei Zhang

Blood (2018) 132 (Supplement 1): 3731.

https://doi.org/10.1182/blood-2018-99-110341

Published: 2018

Journal Articles

Proteomic and Biological Analysis of Myeloma Cell Derived Extracellular Vesicles

Dominique B Hoelzinger, PhD, Sophia J Quinton, Denise K Walters, PhD, Renee C Tschumper, Diane F Jelinek, PhD

Blood (2018) 132 (Supplement 1): 5605.

https://doi.org/10.1182/blood-2018-99-116926

Published: 2018

Journal Articles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Todd Clover, MD MS, Ronald S. Go, MD, Ana G. Antun, MD, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Elizabeth Davis, Andrew Johnson, MD, Ming Yeong Lim, MBBChir, Meera Sridharan, MD, Keith McCrae, MD, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Lisa Baumann-Kreuziger, MS MD

Blood (2017) 130 (Supplement 1): 3624.

https://doi.org/10.1182/blood.V130.Suppl_1.3624.3624

Published: 2017

Journal Articles

Single-Center Experience of the Utility of a Rapid ADAMTS13 Assay

Peter Barth, MD, Ari Pelcovits, MD, John L Reagan, MD

Blood (2017) 130 (Supplement 1): 3630.

https://doi.org/10.1182/blood.V130.Suppl_1.3630.3630

Published: 2017

Journal Articles

Pathophysiology of thrombotic thrombocytopenic purpura

J. Evan Sadler

Blood (2017) 130 (10): 1181–1188.

https://doi.org/10.1182/blood-2017-04-636431

Published: 2017

Journal Articles

Thrombotic thrombocytopenic purpura

Bérangère S. Joly, Paul Coppo, Agnès Veyradier

Blood (2017) 129 (21): 2836–2846.

https://doi.org/10.1182/blood-2016-10-709857

Published: 2017

Journal Articles

ADAMTS13 -/- zebrafish Model Created By Crispr/Cas Reveals a Novel Role of ADAMTS13 in Vascular Development and Prothrombotic Phenotype

Liang Zheng, PhD, X. Long Zheng, MD, PhD

Blood (2016) 128 (22): 1446.

https://doi.org/10.1182/blood.V128.22.1446.1446

Published: 2016

Journal Articles

Platelet-Delivered Recombinant ADAMTS13 Inhibits Platelet Adhesion and Aggregation on Collagen Surface Under Flow in the Presence of Autoantibodies from Acquired Thrombotic Thrombocytopenic Purpura

Mohammad S. Abdelgawwad, MD, M.Sc., Jenny K. McDaniel, MD, Wenjing Cao, MD, PhD, Huy P. Pham, MD, M.P.H., Lance A. Williams, MD, X. Long Zheng, MD, PhD

Blood (2016) 128 (22): 1374.

https://doi.org/10.1182/blood.V128.22.1374.1374

Published: 2016

Journal Articles

Engineering Human Pluripotent Stem Cell-Derived Natural Killer Cells to Prevent CD16a Shedding for Enhanced Anti-Tumor Killing

Robert Blum, MS, Aadithya Arumugam, PhD, Jianming Wu, DVM, PhD, Bruce Walcheck, PhD, Dan Kaufman, MD PhD

Blood (2016) 128 (22): 1336.

https://doi.org/10.1182/blood.V128.22.1336.1336

Published: 2016

Journal Articles

Phylogenetic Analysis Identifies a Subset of ADAMTS13 Domains That Are Highly Conserved and Essential for Allosteric Regulation

Joshua Muia, PhD, Jian Zhu, PhD, Suellen Greco, DVM, Karen Vanhoorelbeke, PhD, Louis Deforche, PhD, Lisa Westfield, Garima Tyagi, PhD, J. Evan Sadler, MD PhD

Blood (2016) 128 (22): 1385.

https://doi.org/10.1182/blood.V128.22.1385.1385

Published: 2016

Journal Articles

ADAMTS18 Metalloproteinase Regulates Angiogenesis In Vivo: Evidence from ADAMTS18 Deficient Mice and Zebrafish

Tiantian Lu, Suying Dang, Wei Zhang, MD PhD

Blood (2016) 128 (22): 1349.

https://doi.org/10.1182/blood.V128.22.1349.1349

Published: 2016

Journal Articles

Proteolytic Inactivation of ADAMTS13 By Activated Factor XI

Kathleen Garland, MD, Owen J.T. McCarty, PhD, Cristina Puy, PhD

Blood (2016) 128 (22): 4955.

https://doi.org/10.1182/blood.V128.22.4955.4955

Published: 2016

NARROW

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Disruption of ADAMTS13-Autoantibody Complexes with an ADAMTS13 Spacer Domain As a Potential Therapeutic Strategy for Immune Thrombotic Thrombocytopenic Purpura

Plasmic and Plasic Αre Εxcellent Predictors of Severe ADAMTS13 Deficiency in Thrombotic Microangiopathy Patients without Secondary Causes

ADAMTS13, an Anti-thrombotic Protein: Evidence Outside of Thrombotic Thrombocytopenic Purpura

Thrombotic Thrombocytopenia Purpura Case Series in Skmc 2016-2017

Characterization and treatment of congenital thrombotic thrombocytopenic purpura

Single Centre UK Comparison of Biosimilar Rituximab (Truxima) with the Originator (MabThera) in Patients with Immune Mediated Thrombotic Thrombocytopenic Purpura

A New Flow-Based Assay to Assess Treatment Response in Congenital Thrombotic Thrombocytopenic Purpura

Vascular Proteomics Reveals Critical Roles of ADAMTS18 in Stroke Associated with Imbalanced Level of Von Willebrand Factor Versus ADAMTS13

Proteomic and Biological Analysis of Myeloma Cell Derived Extracellular Vesicles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Single-Center Experience of the Utility of a Rapid ADAMTS13 Assay

Pathophysiology of thrombotic thrombocytopenic purpura

Thrombotic thrombocytopenic purpura

ADAMTS13 -/- zebrafish Model Created By Crispr/Cas Reveals a Novel Role of ADAMTS13 in Vascular Development and Prothrombotic Phenotype

Platelet-Delivered Recombinant ADAMTS13 Inhibits Platelet Adhesion and Aggregation on Collagen Surface Under Flow in the Presence of Autoantibodies from Acquired Thrombotic Thrombocytopenic Purpura

Engineering Human Pluripotent Stem Cell-Derived Natural Killer Cells to Prevent CD16a Shedding for Enhanced Anti-Tumor Killing

Phylogenetic Analysis Identifies a Subset of ADAMTS13 Domains That Are Highly Conserved and Essential for Allosteric Regulation

ADAMTS18 Metalloproteinase Regulates Angiogenesis In Vivo: Evidence from ADAMTS18 Deficient Mice and Zebrafish

Proteolytic Inactivation of ADAMTS13 By Activated Factor XI

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only